Custom-mixed hormone therapies misleading menopausal women to think personalised products are necessary, experts say

Companies are selling compounded MHT as more ‘natural’ – but there are links with endometrial cancer, the Australian Menopause Society warns

• Get our morning and afternoon news emails, free app or daily news podcast

Prof Susan Davis was shocked to see her name on the website of an Australian telehealth menopause clinic offering a product she believes “is frankly reprehensible” and “misleading women”.

Davis, the director of Monash University’s Women’s Health Research Program, was concerned that the unauthorised use of her name and accompanying quotes suggested she backed the custom-made menopause hormone therapy (MHT) being sold.

Sign up for Guardian Australia’s free morning and afternoon email newsletters for your daily news roundup